Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Archives of Psychiatric Nursing
|
March 9, 1999
Meanings of state hospital nursing. I: Facing challenges
M D Thomas, J Beaven, J Blacksmith, et al.
Annals of the New York Academy of Sciences
|
November 5, 1997
Neuroimaging of vessel amyloid in Alzheimer's disease
R P Friedland, R Kalaria, M Berridge, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 31, 2000
Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results
P L Weiden, H B Breitz, O Press, et al.
American Journal of Physiologic Imaging
|
April 1, 1992
Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography
R L Wahl, N A Swanson, J W Johnson, et al.
Epidemiology and Infection
|
November 27, 2015
Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013
S Vallabhaneni, O Almendares, M M Farley, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 10, 2008
Dual EGFR/ErbB-2 inhibitors from novel pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines
Robert D Hubbard, Scott H Dickerson, Holly K Emerson, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2008
Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors
Kirk L Stevens, Michael J Reno, Jennifer B Alberti, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 18, 2006
Alkynyl pyrimidines as dual EGFR/ErbB2 kinase inhibitors
Alex G Waterson, Kirk L Stevens, Michael J Reno, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2008
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors
Kirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 22, 2008
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases
Edgar R Wood, Lisa M Shewchuk, Byron Ellis, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Archives of Psychiatric Nursing
|
March 9, 1999
Meanings of state hospital nursing. I: Facing challenges
M D Thomas, J Beaven, J Blacksmith, et al.
Annals of the New York Academy of Sciences
|
November 5, 1997
Neuroimaging of vessel amyloid in Alzheimer's disease
R P Friedland, R Kalaria, M Berridge, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
March 31, 2000
Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): initial phase I/II study results
P L Weiden, H B Breitz, O Press, et al.
American Journal of Physiologic Imaging
|
April 1, 1992
Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography
R L Wahl, N A Swanson, J W Johnson, et al.
Epidemiology and Infection
|
November 27, 2015
Epidemiology and factors associated with candidaemia following Clostridium difficile infection in adults within metropolitan Atlanta, 2009-2013
S Vallabhaneni, O Almendares, M M Farley, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 10, 2008
Dual EGFR/ErbB-2 inhibitors from novel pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines
Robert D Hubbard, Scott H Dickerson, Holly K Emerson, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 7, 2008
Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors
Kirk L Stevens, Michael J Reno, Jennifer B Alberti, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 18, 2006
Alkynyl pyrimidines as dual EGFR/ErbB2 kinase inhibitors
Alex G Waterson, Kirk L Stevens, Michael J Reno, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 26, 2008
Synthesis and stereochemical effects of pyrrolidinyl-acetylenic thieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors
Kirk L Stevens, Krystal J Alligood, Jennifer G Badiang Alberti, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 22, 2008
6-Ethynylthieno[3,2-d]- and 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent modifiers of ErbB kinases
Edgar R Wood, Lisa M Shewchuk, Byron Ellis, et al.
Page
of 2